COVID-19 clotting Safety
Covid-19 patients have liability for hyper coagulability, low level laser Therapy improve circulation and decrease liability for hyper coagulability accompanied with circulatory exercises .
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Enrollment
60
Pin pointed application of low level laser on 15 acupuncture points each point 1 min time of application 15 min.
Active assisted or against mild resistance. Supine with leg up position 18degrees measured by the bed water balance in side rails. If patient is not comfortable according to the modified Borg scale or contra indicated for the position then assume the supine position. The subject will have A 3 min rest period to acclimatize themselves to each position. The ankle pumping exercises consisted of simple repetitions of dorsiflexion 1 sec and planter- flexion for 1 sec with three different exercise intervals: * repeated dorsiflexion and planter-flexion with no rest (no rest exercise). * repeated dorsiflexion and planter-flexion with a 2 sec rest period (2 sec rest exercise). * repeated dorsiflexion and planter-flexion with 4sec rest period (4sec rest exercise). Subjects will have practiced ankle pumps before the exercise to get familiar and be educated about the procedure.
Physical therapy faculty
Dokki, Giza Governorate, Egypt
RECRUITINGCirculatory group laboratory investigation.
D-dimer≥.5mg/dL, fibrinogen\>2.5mg/dL To examine COVID-19 recovery.
Time frame: Monthly (an average of two months)
Circulatory group: CBC analysis.
Lymphocyte count\<1.500mm3, Platelet count\<150.000mm3, to examine COVID-19 recovery.
Time frame: Daily (an average of two months)
Circulatory group (PT, PTT).
Prothrombin time\>3 sec, activated partial thromboplastin time\>5 sec to examine COVID-19 recovery.
Time frame: Bi weekly (an average of two months)
Circulatory group physical examination.
by visual analog scale is horizontal line 100mm length the ends defined as extreme limit of the parameter measured (symptom, pain, health) orientated from the left (the worst) the right (the best) 3 times per week to detect DVT.
Time frame: Every two days (an average of two months)
Circulatory group. BMI.
weight kg on height m2 to detect liability for DVT.
Time frame: Day one
Especially Lab investigation.
C-reactive protein ≥10mg/l for diagnosis of the recovery.
Time frame: Baseline
LLLT group laboratory investigation.
D-dimer≥,5mg/dl, fibrinogen\>2.5mg/dl, c-reactive protein≥10mg/dl to examine COVID-19 recovery. Fibrinogen
Time frame: Monthly (an average of two months)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
LLLT group CBC analysis.
lymphocyte count\<1,500mm3, platelet count\<150,000mm3, for examine COVID-19 recovery.
Time frame: Daily (an average of two months)
LLLT group. {PTT, PT}.
Prothrombin time\>3 sec, activated partial thromboplastin time\>5sec to examine COVID-19 recovery.
Time frame: Bi weekly (an average of two months)
LLLT group physical examination.
by visual analog scale is a straight horizontal line of fixed length 100mm the end is extreme limit of the parameter measured (symptom, pain, health) orientated from the left (the worst) to the right (the best) 3times per week to detect DVT.
Time frame: Every two days (an average of two months)
LLLT group. BMI.
Weight kg/height m2 to detect liability for DVT.
Time frame: Day one
Specifically Lab investigation.
C\_reactive protein≥10mg/l.help diagnosis of the recovery.
Time frame: Baseline